About Aseptrol®
The Aseptrol® Platform is an advanced chlorine‑dioxide technology engineered to deliver rapid, reliable disinfection, deodorizing or cleaning without complex equipment, electricity, or specialized delivery systems—providing the power of ClO₂ wherever it’s needed.
Acquired from BASF in 2026 and now part of Oxidium Technologies’ portfolio, Aseptrol offers a variety of complementary formats built on the same core advantage: fast, efficient chlorine dioxide generation. Solution‑generation tablets and powders create high‑purity ClO₂ on demand for surfaces, water treatment, and equipment sterilization, while sustained‑release vapor formulations continuously emit controlled ClO₂ gas for weeks to protect enclosed spaces, cold storage, overseas shipments, and other environments requiring long‑term microbial control.
Aseptrol Technology
EPA-registered antimicrobial solutions across healthcare, manufacturing, and water treatment
Aseptrol antimicrobial technologies are EPA-registered for healthcare and sanitation applications
PURE CHLORINE DIOXIDE RELEASE
Our chlorine Dioxide generation technology is built on chlorine dioxide (ClO₂) release technology that achieves substantially complete conversion. Peer-reviewed studies show ClO₂ is potent against vegetative and spore-forming bacteria.
Regulatory Compliance
Chemical manufacturers face years of regulatory navigation and significant up-front investment when developing disinfectants. Oxidium Technologies eliminates these barriers. We provide established EPA-registered formulations based on proven Aseptrol technology—a chlorine dioxide chemistry developed over decades and developed and commercialized by BASF.
